XJPX
4686
Market cap1.91bUSD
Oct 09, Last price
4,870.00JPY
1D
3.84%
1Q
22.82%
Jan 2017
330.59%
Name
Justsystems Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating predominantly in Japan, JustSystems Corporation is a company dedicated to the creation, development, and delivery of software and associated services. Its diverse product portfolio includes Advanced Technology of Kana-Kanji Transfer, a sophisticated Japanese language input system, and SMILE ZEMI, a tablet-based e-learning platform designed specifically for elementary school children. Additionally, JustSystems offers Actionista!, an intuitive business intelligence solution for data analysis; a range of office productivity software like JUST Office, JUST Government, and JUST Police, tailored to accurately process unique Japanese names and geographical terms; and ATOK Medical, a specialized medical dictionary facilitating the conversion of intricate disease and pharmaceutical terminology. The company's clientele is broad, encompassing individuals, private enterprises, government agencies, local authorities, law enforcement bodies, educational institutions, and healthcare providers. Established in 1979, JustSystems Corporation maintains its headquarters in Tokyo, Japan.
Key people
Kyotaro Sekinada
President, Chief Executive Officer, Representative Director · since 2016
Masayuki Tajiki
Director of Solution Strategy Business, Director · since 2020
Masayuki Miki
Director · since 2009
Yasushi Higo
Independent Director · since 2021
Toru Igarashi
Independent Director · since 2021
Tsutomu Kumagai
Independent Director · since 2021
Independent Director · since 2019
Yoshie Midorikawa
Independent Director · since 2023
Katsuji Nagasawa
Independent Director · since 2025
Headquarters & legal address
川内町平石若松108番地4
徳島市, 36 771-0189
JP
徳島市, 36 771-0189
JP
Other language
JustSystems Corporation
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||